Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3643709
Max Phase: Preclinical
Molecular Formula: C20H26F3NO3
Molecular Weight: 385.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3643709
Max Phase: Preclinical
Molecular Formula: C20H26F3NO3
Molecular Weight: 385.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCC[C@@H]1C[C@@]2(CC[C@H]1O)CCN(c1ccc(OCC(F)(F)F)cc1)C2=O
Standard InChI: InChI=1S/C20H26F3NO3/c1-2-3-14-12-19(9-8-17(14)25)10-11-24(18(19)26)15-4-6-16(7-5-15)27-13-20(21,22)23/h4-7,14,17,25H,2-3,8-13H2,1H3/t14-,17-,19-/m1/s1
Standard InChI Key: QGVFVHFQCBELNT-LSBZLQRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 385.43 | Molecular Weight (Monoisotopic): 385.1865 | AlogP: 4.31 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.77 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.82 | Np Likeness Score: -0.03 |
1. (2014) SEC-hydroxycyclohexyl derivatives, |
Source(1):